Abstract
RATIONALE: Multiple strengths of mometasone furoate/formoterol (MF/F) MDI combination therapy are under investigation as new treatments for asthma. We report efficacy/safety findings from a 3-month MF/F study in subjects with severe asthma.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have